Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Brain Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cholangiocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
DNA Mismatch Repair (Phase 2)
Drug Evaluation (Phase 1/Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 2)
Glioblastoma (Phase 1)
Healthy Volunteers (Phase 1)
Immune Checkpoint Inhibitors (Phase 1/Phase 2)
Immunotherapy (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 1/Phase 2)
Melanoma (Phase 1/Phase 2)
Mesothelioma (Phase 2)
Microsatellite Instability (Phase 2)
Nasopharyngeal Carcinoma (Phase 3)
Nasopharyngeal Neoplasms (Phase 3)
Neoadjuvant Therapy (Phase 2)
Neoplasm Metastasis (Phase 1/Phase 2)
Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Radiosurgery (Phase 1/Phase 2)
Rectal Neoplasms (Phase 2)
Safety (Phase 1/Phase 2)
Sarcoma (Phase 2)
Small Cell Lung Carcinoma (Phase 1/Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Vulvar Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue